Follow The Filings

RPID Rapid Micro Biosystems

Rapid Micro Biosystems earnings company data as of 7:50 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by RPID's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RPID insider trades
  • None no insider bought on the open market
  • $664K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Longitude Capital Partners II, LLC 10% owner, +5 joint filers
    Sale
    $190K 49,000 shares at $3.88 100% of stake
    Traded Feb 4 Filed Feb 6
    ↗
  2. Longitude Capital Partners II, LLC 10% owner, +4 joint filers
    Sale
    $474K 108,739 shares at $4.36 69% of stake
    Traded Jan 23–Feb 3 Filed Feb 3
    ↗

Also filed in the last 12 months, not counted as buying or selling: 13 stock grants, 9 sales to cover taxes, 5 option exercises, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.